Aim: The present work aimed at the DIM-loaded microparticles development and anti-hypernociceptive action evaluation.
Method: The formulations were prepared by O/W solvent emulsion-evaporation method and characterised by particle diameter, content and DIM encapsulation efficiency, drug release profile, thermal behaviour and physicochemical state. The anti-hypernociceptive action was evaluated in the animal model of acute inflammatory pain.
Result: The MPs had a mean diameter in the micrometric range (368 ± 31 μm), narrow size distribution, DIM content of 150 mg/g, encapsulation efficiency around 84% and prolonged compound release. Evaluations of the association form of DIM to MPs demonstrated the feasibility of the systems to incorporate DIM and increases its thermal stability. An improvement in the anti-hypernociceptive action of DIM was observed by its microencapsuation, because it was increased and prolonged.
Conclusion: Therefore, the MPs developed represent a promising formulation for oral administration of the DIM in the treatment of inflammatory pain.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1080/02652048.2020.1815882 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Ethylcellulose microparticles enhance 3,3'-diindolylmethane anti-hypernociceptive action in an animal model of acute inflammatory pain.
J Microencapsul
November 2020
Programa de Pós-graduação em Ciências Farmacêuticas, Laboratório de Tecnologia Farmacêutica, Departamento de Farmácia Industrial, Centro de Ciências da Saúde, Federal University of Santa Maria, Santa Maria, Brazil.
Aim: The present work aimed at the DIM-loaded microparticles development and anti-hypernociceptive action evaluation.
Method: The formulations were prepared by O/W solvent emulsion-evaporation method and characterised by particle diameter, content and DIM encapsulation efficiency, drug release profile, thermal behaviour and physicochemical state. The anti-hypernociceptive action was evaluated in the animal model of acute inflammatory pain.
Pain-Relieving Effectiveness of Co-Treatment with Local Tramadol and Systemic Minocycline in Carrageenan-Induced Inflammatory Pain Model.
Inflammation
August 2018
School of Health Sciences, Kahramanmaras Sutcu Imam University, 46050, Kahramanmaras, Turkey.
Article Synopsis
- This study tested the idea that using minocycline to inhibit microglial activation could reduce how much tramadol is needed for pain relief in inflammation.
- The research involved injecting tramadol and minocycline in a rat model to measure their effects on pain, swelling, and inflammation markers in tissues.
- Results showed that using both drugs together significantly improved pain relief and reduced inflammatory cytokines compared to using either treatment alone, suggesting this combination could be a better option for treating inflammatory pain.
p,p'-Methoxyl-diphenyl diselenide-loaded polymeric nanocapsules as a novel approach to inflammatory pain treatment: Behavioral, biochemistry and molecular evidence.
Eur J Pharm Sci
January 2018
Programa de Pós-graduação em Bioquímica Toxicológica, Laboratório de Síntese, Reatividade e Avaliação Farmacológica e Toxicológica de Organocalcogênios, Departamento de Biologia Molecular, Centro de Ciências Naturais e Exatas, Universidade Federal de Santa Maria, Santa Maria, CEP 97105-900, RS, Brazil. Electronic address:
The current study investigated the effect of organoselenium compound p,p'-methoxyl-diphenyl diselenide [(OMePhSe)], free or incorporated into nanocapsules, on behavioral, biochemical and molecular alterations in an inflammatory pain model induced by complete Freund's adjuvant (CFA). Male Swiss mice received an intraplantar injection of CFA in the hindpaw and 24 h later they were treated via the intragastric route with a single (OMePhSe) administration, in its free form (dissolved in canola oil) or (OMePhSe) NC. The anti-hypernociceptive time- and dose-response curves were carried out using the von Frey hair test.
View Article and Find Full Text PDFAnti-hyperalgesic activity of the aqueous and methanol extracts of the leaves of Pittosporum mannii Hook on CFA-induced persistent inflammatory pain.
Inflammopharmacology
February 2018
Laboratory of Animal Physiology and Phytopharmacology, University of Dschang, P.O.Box 67, Dschang, Cameroon.
Background: Previous study showed that aqueous (AEPM) and methanol (MEPM) extracts from the leaves of Pittosporum mannii have analgesic effects in acute pain models. The present study evaluates the acute and chronic anti-hypernociceptive and anti-inflammatory effects of AEPM and MEPM in a model of persistent inflammatory pain.
Methods: The third day after induction of inflammatory pain by subplantar injection of 100 µL of CFA in Wistar rats, AEPM and MEPM were administered orally (75, 150 and 300 mg/kg/day) and their anti-hyperalgesic and anti-inflammatory effects were follow in acute (1-24 h) and chronic (for 14 days) treatments.
Anti-hypernociceptive and anti-oxidative effects of locally treated dobutamine in diabetic rats.
Pharmacol Rep
October 2015
Neurosurgery, School of Medicine, Kahramanmaras Sutcu Imam University, Kahramanmaras, Turkey.
Background: Oxidative stress as a significant factor in the development of diabetes induced neuropathic pain as well as the potential for prevention of this complication. Therefore, we hypothesized that locally administrated dobutamine, a beta-adrenoreceptor agonist, or esmolol, a beta-adrenoreceptor antagonist, can modulate the oxidative stress and ameliorate the diabetes induced neuropathic pain.
Methods: Effects of locally (intraplantar) treated two pharmaceutical preparations used in clinical applications, dobutamine or esmolol, were investigated by measuring thermal latencies, mechanical thresholds and several oxidative stress parameters in streptozotocin (STZ) induced diabetic rats.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!